Partnerships for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)
ArchivedNational Institutes of Health
Description
The objective of this initiative is to support milestone-driven projects focused on the development of clinically informative diagnostic platforms that identify select antimicrobial-resistant bacterial pathogens and determine associated antimicrobial sensitivity and/or resistance. Applications must include a Product Development Strategy and demonstrate substantive investment by at least one industrial participant.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedJun 1, 2017
- ClosesOct 4, 2017
- CFDA93.855, 93.856
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro